コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 LOF causes pathogenic lipid accumulation in microglia.
2 ma 2 (AIM2) inflammasome in primary cultured microglia.
3 ce, which enable highly specific ablation of microglia.
4 ZL0580 on HIV long terminal repeat (LTR) in microglia.
5 esulted in degradation of LAMP2 in activated microglia.
6 also displayed increased numbers of rod-like microglia.
7 resented in blood-derived macrophages versus microglia.
8 hyper-reflectivity overlapped with activated microglia.
9 ed by increased colabeling of astrocytes and microglia.
10 BPbeta-dependent gene expression programs in microglia.
11 d co-cultured them with or without activated microglia.
12 etected in a subset of astrocytes and in the microglia.
13 tors for the breaking of immune tolerance of microglia.
14 ession of neurological disease-risk genes in microglia.
15 ta expression, activation of astrocytes, and microglia.
16 in multiple cell types including neurons and microglia.
17 TREM2 is a receptor for lipids expressed in microglia.
18 reasing the prevalence of disease-associated microglia.
19 assays on Pten wild-type and Pten(m3m4/m3m4) microglia.
20 rogenitor-like cells are present among adult microglia.
21 ce in the brain is uptake and degradation by microglia.
22 cit enhanced pruning from innately activated microglia.
23 receptors are expressed in primary cultured microglia.
24 ress through NADPH oxidase in lineage-traced microglia.
25 tic PS exposure and reduced PS engulfment by microglia.
26 is not known, but it involves activation of microglia.
27 genic mice were also used to delete Lpar1 in microglia.
28 herally-derived myeloid cells and endogenous microglia.
29 ns and their interaction with hyper-ramified microglia.
30 y Ly49D(+) NK cells and neutrophils, but not microglia.
31 aR1 responses contribute to TLQP21 action on microglia.
32 heimer's disease (AD) risk gene expressed in microglia.
35 tation was associated with reduced astrocyte/microglia activation and downregulation of the transcrip
36 that APN deficiency increased Abeta-induced microglia activation and neuroinflammatory responses in
39 ese data, protein aggregate accumulation and microglia activation were observed in the spinal cord wh
40 ing a cascade of molecular events leading to microglia activation, perineural net degradation, and im
44 ate that chronic phase removal of neurotoxic microglia after TBI using CSF1R inhibitors markedly redu
45 progranulin, and reduction of progranulin in microglia alone is sufficient to recapitulate inflammati
48 ppressing neuronal activity, and ablation of microglia amplifies and synchronizes the activity of neu
49 or 1 receptor inhibitor (PLX5622) to deplete microglia and a chronic intermittent ethanol vapor two-b
50 with (i) 11C-PK-11195, a marker of activated microglia and a proxy index of neuroinflammation; and (i
51 s enriched in AD genetic risk factors and in microglia and astrocyte protein markers associated with
53 ely parallel single-cell analyses to compare microglia and CAM signatures during homeostasis and dise
56 e a deeper understanding of both parenchymal microglia and extraparenchymal brain macrophages in home
57 -inducible Cre-mediated gene manipulation in microglia and for fate mapping of microglia but not CAMs
59 elevated frequencies of inflammatory M1-like microglia and increased release of pro-inflammatory cyto
60 FIRE) embryos, the arrival of both primitive microglia and intracerebroventricular macrophages was el
67 we analyzed the effect of NPC1 deficiency on microglia and on climbing fiber synaptic refinement duri
69 that the phenotypic differentiation between microglia and peripheral macrophages is age-dependent an
71 neuroinflammation.IMPORTANCE Brain-resident microglia and perivascular macrophages are important HIV
72 lammatory response by using Kv1.3-KO primary microglia and the Kv1.3-specific small-molecule inhibito
73 stem hosts parenchymal macrophages, known as microglia, and non-parenchymal macrophages, collectively
74 tical impact to remove chronically activated microglia, and the inhibitor was withdrawn 1-week later
75 Infiltration of T lymphocytes, activation of microglia, and their interplay are the primary pathophys
77 d that juxtavascular microglia migrated when microglia are actively colonizing the cortex and became
79 talls the regrowth of axons, suggesting that microglia are critical for orchestrating the injury resp
80 The beneficial effects of these repopulating microglia are critically dependent on interleukin-6 (IL-
82 nt macrophages of the brain and spinal cord, microglia are crucial for the phagocytosis of infectious
88 the healthy adult mouse brain, we show that microglia are necessary for the normal functional develo
91 that Arg1-mediated alternative activation of microglia are potential therapeutic targets for psychiat
95 , which contradict the current paradigm that microglia are the main immune effector cells of the CNS.
99 naive littermates, suggesting a new role for microglia as homeostatic regulators of perineuronal net
101 Here, we highlight the fundamental role of microglia as tissue-resident macrophages in neuronal hea
103 icient PS1 show severe Abeta accumulation in microglia as well as the postsynaptic protein PSD95.
104 l cortex to show that a higher percentage of microglia associate with the vasculature during the firs
105 humans and rodents provide new insight into microglia-astrocyte communication in homeostasis and dis
108 ABAergic) and nonneuronal (oligodendrocytes, microglia, astrocytes, and endothelial) cell types.
109 ns, GABAergic neurons, oligodendrocytes, and microglia/astrocytes) from three different brain regions
113 To resolve these issues we directly observed microglia behaviors with two-photon microscopy in ex viv
114 itiating cells induce mTOR signalling in the microglia but not bone marrow-derived macrophages in bot
116 morphology and metabolism in the absence of microglia, but no effect of Cxcl10 was observed on micro
117 rve injury-induced activation of spinal cord microglia, but the responsible endogenous TLR2 agonist h
118 ally, ZL0580 inhibits Tat transactivation in microglia by disrupting binding of Tat to CDK9, a proces
121 ol milk formula for 5 d or from hypothalamic microglia cells obtained from postnatal rats, grown in c
123 Using fixed- and live-cell imaging in human microglia cells, we further show that CLASP2 is required
127 port that during colonization of the retina, microglia contacts the deep layer of high stiffness, whi
131 se subunit beta (Hexb) as a stably expressed microglia core gene, whereas other microglia core genes
132 expressed microglia core gene, whereas other microglia core genes were substantially downregulated du
133 Confocal 3D analyses revealed increased microglia coverage of the motoneuron cell body surface w
134 In addition, we found evidence for neuron-microglia cross-talk, where Pten(m3m4/m3m4) neurons elic
136 t indapamide reduced superoxide derived from microglia cultures and that treatment of middle-aged mic
137 D risk, and activation of disease-associated microglia (DAM) is dependent on TREM2 in mouse models of
138 At the cellular level in these animals, microglia depletion reduced inhibitory GABA(A) and excit
139 inhibition has been proposed as a method for microglia depletion, with the assumption that it does no
143 ly identified to be upregulated by activated microglia during aging, neurodegeneration, or loss of Sa
144 rall, we show that short-term elimination of microglia during the chronic phase of TBI followed by re
145 ouse technology, we show that IL-1-dependent microglia-endothelia cross talk is necessary for eliciti
146 reover, we detected activated ISG-expressing microglia enveloping NA-containing neuritic plaques in p
152 bolic function in human patient iPSC-derived microglia expressing loss of function variants in TREM2.
153 in phagocytosis of postsynaptic elements by microglia expressing TREM2R47H in the PS19 mice and in h
155 we found that mTOR is strongly activated in microglia following excitatory injury elicited by status
156 We developed a reliable technique to stain microglia from epileptic and glioma patients to examine
159 e that in coming years, a clearer picture of microglia function in health and disease will emerge.
161 echanisms by which the p.R47H variant of the microglia gene and Alzheimer's disease (AD) risk factor
164 a provide evidence that dysregulated Pten in microglia has an etiological role in microglial activati
169 erleukin-10 (IL-10) axis in restoring murine microglia homeostasis following a peripheral endotoxin c
172 ated the normal and disrupted development of microglia in barrel cortex by chronically depriving sens
174 ss the complementary roles of astrocytes and microglia in building the brain, including in the format
176 ling of thousands of neurons, astrocytes, or microglia in each brain, revealing their intricate morph
178 synapses, but active synaptic remodeling by microglia in mature healthy brains is rarely directly ob
181 veals a neuronal activity-regulated role for microglia in modifying developmental myelin targeting by
184 tor 1 (IGF1) is produced by tumor-associated microglia in response to interleukin-4 (IL-4) stimulatio
186 (TREM2), a receptor exclusively expressed by microglia in the brain, modulates microglial immune home
188 and increased markers indicative of reactive microglia in the cerebellum, cortex and hippocampus rela
189 ell contact was required for N1 to influence microglia in the co-cultures, and this was linked with r
193 is of the changes induced by phagocytosis in microglia in vitro and identified genes involved in meta
195 suggesting that signals provided by reactive microglia influence how NF-kappaB impacts Muller glia re
196 are not expressed in astroglia and rarely in microglia; instead, glutamatergic neurons express LepR,
198 propose that functional perturbation of male microglia is an important cause for sex-biased ASD.
199 tory response in 5xFAD mice and suggest that microglia is central to the association between PD and A
201 Importantly, co-manipulation of GPR17 and microglia led to extensive myelination of regenerated ax
202 ere, we establish isogenic human ESC-derived microglia-like cell lines (hMGLs) harboring AD variants
203 human induced pluripotent stem cell-derived microglia-like cells to show that TREM2 signals through
205 t and deliver drugs selectively to activated microglia/macrophages at the sites of injury, and suppre
207 ma of infected mice with persistent CD11b(+) microglia/macrophages in the inflamed regions on day 30
209 ux of lipid and cholesterol from lipid-laden microglia/macrophages to support remyelination by oligod
212 e most extensive versatility in manipulating microglia, making them ideal candidates for future studi
213 pment of alcohol dependence, suggesting that microglia may also be critical for the development and p
216 ctivity in stress-induced CSF1 signaling and microglia-mediated neuronal remodeling in the medial PFC
217 onic stress-induced neuronal activity limits microglia-mediated neuronal remodeling in the medial PFC
218 imaging in mice, we found that juxtavascular microglia migrated when microglia are actively colonizin
219 These deficits correlate with alterations of microglia-neuron crosstalk pathways and have long-lastin
220 Understanding how to assess and modulate microglia-neuron interactions critical for brain health
223 nalysis using markers of myelin, astrocytes, microglia, neurons, globoid cells, and immune cells.
227 ar endothelial cells, pericytes, astrocytes, microglia, oligodendrocytes and neurons to model the eff
228 isualize and manipulate interactions between microglia, oligodendrocytes, and neurons during developm
231 is necessary for eliciting this spinal cord microglia phenotype and also for conferring optimal prot
232 ge bodies in AF(+) cells and led to impaired microglia physiology and cell death, suggestive of a mec
234 ASO treatment shifted the composition of the microglia population by increasing the prevalence of dis
235 , neuronal Mfn2 suppressed the activation of microglia, prevented LPS-induced mitochondrial fragmenta
239 n in the CeA, supporting the hypothesis that microglia regulate dependence-induced changes in neurona
240 al fluid (CSF), we measured 3 macrophage and microglia-related proteins, chitotriosidase (CHIT1), chi
241 the absence of murine CD4 T cells, resident microglia remained suspended between the fetal and adult
242 s, while conditional Mef2c heterozygosity in microglia reproduced social deficits and repetitive beha
247 n intercellular signaling axis through which microglia shape retinogeniculate connectivity in respons
248 t the molecular level, the proteome of AF(+) microglia showed overrepresentation of endolysosomal, au
249 of adult mice, and found that both types of microglia significantly improved healing and axon regrow
251 binds GPR56 in a domain-specific manner, and microglia-specific deletion of Gpr56 leads to increased
252 express some of the most commonly described microglia-specific markers early during development, suc
253 ur findings demonstrate for the first time a microglia-specific mechanism of RICD involving an upstre
255 t evidence that tumor-associated macrophages/microglia (TAMs) can promote tumor progression in the so
257 iciency leads to early phenotypic changes in microglia that are not associated with an innate immune
258 a molecular interaction between neurons and microglia that drives experience-dependent synapse remod
265 cently sparked numerous exciting findings on microglia, the resident macrophages of the central nervo
266 -38 in the inhibition of activation of human microglia, thus supporting its development as a treatmen
269 which, in turn, produce IL-4 that stimulates microglia to produce IGF1 to promote tumor progression.
271 r multifaceted approach is the first to link microglia to the molecular, cellular, and behavioral cha
272 enuates proliferation and/or infiltration of microglia to the region thereby curtailing the deleterio
274 nsplanted either neonatal microglia or adult microglia treated with peptidase inhibitors into spinal
275 geniculate connections near TWEAK-expressing microglia, TWEAK signals via Fn14 to restrict the number
282 macological removal of chronically activated microglia using a colony stimulating factor 1 receptor (
285 nt in neuronal and non-neuronal (astrocytes, microglia, vascular endothelial cells) cells of cortical
286 his mechanism underlies an interplay between microglia, vascular patterning and tissue mechanics with
288 possible to consistently elicit spinal cord microglia via systemic delivery of inflammogens to achie
289 se microglial defects in Grn-deficient mouse microglia, we performed a compound screen coupled with h
293 fferentiate between sample treatment groups, microglia were stimulated with the endotoxin lipopolysac
295 P21 can modulate the functional phenotype of microglia, which may have an impact on their function in
296 e complexes potentiate inflammation by human microglia, which may play an important role in MS-associ
298 opulations under CSF1R inhibition, including microglia with reduced homeostatic markers and elevated
300 Live imaging revealed that juxtavascular microglia within the cortex are highly motile and migrat